Evaluating the risk of manganese-induced neurotoxicity of parenteral nutrition: review of the current literature. (4th May 2021)

• Record Type: Journal Article
• Authors: Martins, Airton C.; Ruella Oliveira, Silvana; Barbosa, Fernando; Tinkov, Alexey A.; V. Skalny, Anatoly; Santamaría, Abel; Lee, Eunsook; Bowman, Aaron B.; Aschner, Michael
• Is Part Of: Expert opinion on drug metabolism and toxicology. Volume 17:Number 5(2021)
• Page Start: 581
• Page End: 593
• Publication Date: 2021-05-04
• Subjects: Heavy metals -- nutrition -- neurotoxicity -- parenteral nutrition -- trace elements -- manganese; Drugs -- Toxicology -- Periodicals; Drugs -- Metabolism -- Periodicals; 615.7
• DOI: 10.1080/17425255.2021.1894123
• Languages: English
• ISSNs: 1742-5255

Abstract

ABSTRACT: Introduction: Several diseases and clinical conditions can affect enteral nutrition and adequate gastrointestinal uptake. In this respect, parenteral nutrition (PN) is necessary for the provision of deficient trace elements. However, some essential elements, such as manganese (Mn) may be toxic to children and adults when parenterally administered in excess, leading to toxic, especially neurotoxic effects. Areas covered: Here, we briefly provide an overview on Mn, addressing its sources of exposure, the role of Mn in the etiology of neurodegenerative diseases, and focusing on potential mechanisms associated with Mn-induced neurotoxicity. In addition, we discuss the potential consequences of overexposure to Mn inherent to PN. Expert opinion: In this critical review, we suggest that additional research is required to safely set Mn levels in PN, and that eliminating Mn as an additive should be considered by physicians and nutritionists on a case by case basis in the meantime to avoid the greater risk of neurotoxicity by its presence. There is a need to better define clinical biomarkers for Mn toxicity by PN, as well as identify new effective agents to treat Mn-neurotoxicity. Moreover, we highlight the importance of the development of new guidelines and practice safeguards to protect patients from excessive Mn exposure and neurotoxicity upon PN administration.